For immediate release: November 17, 2005
VANCOUVER – Inex Pharmaceuticals Corporation ("INEX"; TSX: IEX) announced today that it will hold a conference call and webcast on Thursday, November 17, 2005 at 1:30 p.m. PST (4:30 pm EST) to provide an update on developments at the Company including the November 17, 2005 announcement to spin-off the Company’s Targeted Immunotherapy assets.
About the Conference Call
To participate in the conference call, please dial 416-641-6130 or 1-866-226-1798. The call will be available for replay until November 27, 2005 by calling 416-695-5800 or 1-800-408-3053 and entering the pass code 3160540#.
The live or archived webcast can be accessed through the Company’s website at www.inexpharm.com.
About INEX
INEX is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer. Further information about INEX and can be found at www.inexpharm.com.
Contact Information
Investors
Ian Mortimer
Vice President, Finance and Chief Financial Officer
Phone: 604-419-3200
Email: info@inexpharm.com
Website: www.inexpharm.com
Media
Karen Cook Boas
James Hoggan & Associates Inc.
Phone: 604-739-7500
Email: kcook@hoggan.com
